Potential of novel dextran oligosaccharides as prebiotics for obesity management through in vitro experimentation

British Journal of Nutrition

Volumn 112, Issue 8, 2014, Pages 1303-1314

  Sarbini, Shahrul R ^a   Kolida, Sofia ^b   Deaville, Eddie R ^b   Gibson, Glenn R ^b   Rastall, Robert A ^b  

^a DEPARTMENT OF CROP SCIENCE   (Malaysia)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Dextrans; Gut microbiota; Obesity; Prebiotics; SCFA

Indexed keywords

ANTIOBESITY AGENT; DEXTRAN OLIGOSACCHARIDE; PREBIOTIC AGENT; UNCLASSIFIED DRUG; DEXTRAN; INULIN; OLIGOSACCHARIDE; VOLATILE FATTY ACID;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; BACTEROIDES; BODY COMPOSITION; CONTROLLED STUDY; FAECALIBACTERIUM PRAUSNITZII; FECES MICROFLORA; FERMENTATION TECHNIQUE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; OBESITY; PH MEASUREMENT; PREVOTELLA; RUMINOCOCCUS; RUMINOCOCCUS BROMII; RUMINOCOCCUS FLAVEFACIENS; BATCH CELL CULTURE; BIFIDOBACTERIUM; BODY MASS; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DIET THERAPY; FECES; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR TYPING;

BACTERIA (MICROORGANISMS); BACTEROIDES; FAECALIBACTERIUM PRAUSNITZII; PREVOTELLA; RUMINOCOCCUS;

ADULT; ANTI-OBESITY AGENTS; BACTEROIDES; BATCH CELL CULTURE TECHNIQUES; BIFIDOBACTERIUM; BODY MASS INDEX; DEXTRANS; FATTY ACIDS, VOLATILE; FECES; FERMENTATION; HUMANS; INULIN; MALE; MICROBIAL VIABILITY; MOLECULAR STRUCTURE; MOLECULAR TYPING; MOLECULAR WEIGHT; OBESITY; OLIGOSACCHARIDES; PREBIOTICS; PREVOTELLA;

EID: 84922017600     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514002177     Document Type: Article

References (49)

1. Macfarlane S & Macfarlane GT (2003) Food and the large intestine. In Gut Flora, Nutrition, Immunity and Health, pp. 24-51 [R Fuller and G Perdigon, editors]. Oxford: Blackwell Publishing.
2. Gibson GR, Scott KP, Rastall RA, et al. (2010) Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods 7, 1-19.
3. Sarbini SR, Kolida S, Gibson GR, et al. (2013) In vitro fermentation of commercial α-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr 109, 1980-1989.
4. Van Geel-Schutten GH, Faber EJ, Smit E, et al. (1999) Biochemical and structural characterization of the glucan and fructan exopolysaccharides synthesized by the Lactobacillus reuteri wild-type strain and by mutant strains. Appl Environ Microbiol 65, 3008-3014.
5. Valette P, Pelenc V, Djouzi Z, et al. (1993) Bioavailability of new synthesised glucooligosaccharides in the intestinal tract of gnotobiotic rats. J Sci Food Agric 62, 121-127.
6. Djouzi Z, Andrieux C, Pelenc V, et al. (1995) Degradation and fermentation of α-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats. J Appl Microbiol 79, 117-127.
7. Sarbini SR, Kolida S, Naeye T, et al. (2011) In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol 77, 5307-5315.
8. Sarbini SR, Kolida S, Naeye T, et al. (2013) The prebiotic effect of α-1,2 branched, low molecular weight dextran in the batch and continuous faecal fermentation system. J Funct Foods 5, 1938-1946.
9. Eckburg PB, Bik EM, Bernstein CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
10. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131.
11. Bäckhed F, Manchester JK, Semenkovich CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104, 979-984.
12. Ley RE, Bäckhed F, Turnbaugh P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 11070-11075.
13. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
14. Collado MC, Isolauri E, Laitinen K, et al. (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88, 894-899.
15. Duncan SH, Lobley GE, Holtrop G, et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32, 1720-1724.
16. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724e1712.
17. Murphy EF, Cotter PD, Healy S, et al. (2010) Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59, 1635-1642.
18. Cani PD, Neyrinck AM, Fava F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.
19. Gibson GR, Probert HM, Loo JV, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259-275.
20. Sarbini SR & Rastall RA (2011) Prebiotics: metabolism, structure and function. Funct Food Rev 3, 93-106.
21. Grimoud J, Durand H, Courtin C, et al. (2010) In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics. Anaerobe 16, 493-500.
22. Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736.
23. Jia W, Whitehead RN, Griffiths L, et al. (2010) Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 310, 138-144.
24. Macfarlane GT, Gibson GR & Cummings JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Microbiol 72, 57-64.
25. Fukuda S, Toh H, Hase K, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547.
26. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, et al. (2010) Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 1801, 1175-1183.
27. Kennedy A, Martinez K, Chuang C-C, et al. (2009) Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 139, 1-4.
28. Boden G (2008) Obesity and free fatty acids. Endocrinol Metab Clin North Am 37, 635-646.
29. Ruijschop RMAJ, Boelrijk AEM & te Giffel MC (2008) Satiety effects of a dairy beverage fermented with propionic acid bacteria. Int Dairy J 18, 945-950.
30. Gao Z, Yin J, Zhang J, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517.
31. Fleischman A, Kron M, Systrom DM, et al. (2009) Mitochondrial function and insulin resistance in overweight and normal-weight children. J Clin Endocrinol Metab 94, 4923-4930.
32. Duncan SH, Belenguer A, Holtrop G, et al. (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrateproducing bacteria in feces. Appl Environ Microbiol 73, 1073-1078.
33. Cummings JH (1995) Short chain fatty acids. In Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, pp. 101-130 [GR Gibson and GT Macfarlane, editors]. Boca Raton, FL: CRC Press.
34. Delzenne NM & Kok N (2001) Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr 73, 456S-458S.
35. 13C]acetate into plasma lipids in humans. Am J Clin Nutr 61, 1241-1247.
36. Kudoh K, Shimizu J, Ishiyama A, et al. (1999) Secretion and excretion of immunoglobulin A to cecum and feces differ with type of indigestible saccharides. J Nutr Sci Vitaminol 45, 173-181.
37. Levitt MD, Gibson GR & Christl SU (1995) Gas metabolism in the large intestine. In Human Colonic Bacteria: Role in Nutrition, Physiology and Health, pp. 113-154 [GR Gibson and GT Macfarlane, editors]. Boca Raton, FL: CRC Press.
38. Nishimura N, Tanabe H, Adachi M, et al. (2013) Colonic hydrogen generated from fructan diffuses into the abdominal cavity and reduces adipose mRNA abundance of cytokines in rats. J Nutr 143, 1943-1949.
39. Tuohy KM, Kolida S, Lustenberger AM, et al. (2001) The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides? a human volunteer study. Br J Nutr 86, 341-348.
40. Hartemink R & Rombouts FM (1997) Gas formation from oligosaccharides by the intestinal microflora. In Non-Digestible Oligosaccharides: Healthy Food for the Colon? Proceedings of the International Symposium, pp. 57-66 [R Hartemink, editor]. Wageningen: Wageningen Graduate School VLAG.
41. Smiricky-Tjardes MR, Flickinger EA, Grieshop CM, et al. (2003) In vitro fermentation characteristics of selected oligosaccharides by swine fecal microflora. J Anim Sci 81, 2505-2514.
42. Franks AH, Harmsen HJM, Raangs GC, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336-3345.
43. Harmsen HJM, Elfferich P, Schut F, et al. (1999) A 16S rRNAtargeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11, 3-12.
44. Walker AW, Duncan SH, McWilliam Leitch EC, et al. (2005) pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 71, 3692-3700.
45. Hold GL, Schwiertz A, Aminov RI, et al. (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69, 4320-4324.
46. Harmsen HJM, Raangs GC, He T, et al. (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68, 2982-2990.
47. Manz W, Amann R, Ludwig W, et al. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of thephylumcytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 1097-1106.
48. Langendijk P, Schut F, Jansen G, et al. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61, 3069-3075.
49. Harmsen HJM, Wildeboer-Veloo ACM, Grijpstra J, et al. (2000) Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66, 4523-4527.